$AME

DA Davidson reiterates Ametek stock buy rating on acquisition close

DA Davidson reiterated a Buy rating and $285 price target for Ametek Inc. (NYSE:AME) after its acquisition of Indicor Instrumentation, citing strategic alignment and strong financial health. The stock has gained 41% over the past year, with analysts revising earnings upwards and maintaining strong dividend payments. Ametek recently reported Q2 2026 earnings of $2.09 per share on revenue of $2.04 billion, exceeding expectations and raising its full-year outlook.

Original reporting
Published Oct 7, 2026, 1:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 2:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

The reiteration of a Buy rating and a higher price target may attract new buying interest, supporting short-term price appreciation.

02

Market read

Analyst endorsement after a major acquisition could drive the stock higher in the near term.

03

What to watch

Potential regulatory scrutiny or integration challenges are not addressed in the analyst note.

Relevance 6/10Novelty 5/10Timing: today

Background

Ametek (NYSE:AME) recently reported strong Q2 results and raised its outlook, while multiple analysts upgraded their targets following the Indicor acquisition.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

DA Davidson reiterated a Buy rating and $285 price target after Ametek closed its acquisition of Indicor Instrumentation.

Expected impact

likely upward pressure as investors price in the higher target and synergies.

Evidence & confidence

The rating reiteration and new price target reflect fresh optimism; the deal adds $550M of aftermarket exposure, suggesting material upside.

Market effects

The deal reinforces Ametek's position in industrial instrumentation, potentially boosting peers in the sector.

U.S. industrial sector may see modest gains as the acquisition signals consolidation.

Limited to industrial equipment space; no broad market effect.

Counterpoint

The acquisition could strain Ametek's balance sheet if integration costs exceed expectations.

Key entities

  • Ametek Inc.

    Industrial instrumentation manufacturer completing the Indicor acquisition.

  • DA Davidson

    Equity research firm issuing the reiterated Buy rating.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.